DI TRANA, ANNAGIULIA
 Distribuzione geografica
Continente #
NA - Nord America 619
EU - Europa 247
AS - Asia 120
AF - Africa 37
OC - Oceania 2
Totale 1.025
Nazione #
US - Stati Uniti d'America 618
IT - Italia 87
CN - Cina 52
SE - Svezia 50
IE - Irlanda 48
SG - Singapore 39
CI - Costa d'Avorio 34
GB - Regno Unito 16
FR - Francia 13
DE - Germania 12
TR - Turchia 9
IN - India 8
UA - Ucraina 6
GE - Georgia 5
MA - Marocco 3
TW - Taiwan 3
AU - Australia 2
BE - Belgio 2
ES - Italia 2
FI - Finlandia 2
HU - Ungheria 2
MK - Macedonia 2
NL - Olanda 2
AT - Austria 1
CA - Canada 1
CH - Svizzera 1
ID - Indonesia 1
JP - Giappone 1
KR - Corea 1
PH - Filippine 1
PL - Polonia 1
Totale 1.025
Città #
Chandler 119
Des Moines 82
Fairfield 49
Dublin 48
Boardman 47
Ashburn 36
Abidjan 34
Seattle 22
Woodbridge 17
Cambridge 16
Ancona 15
Turin 15
Wilmington 15
Houston 14
Lawrence 14
Princeton 14
Jacksonville 13
Singapore 13
Ann Arbor 8
Los Angeles 8
San Mateo 8
Shanghai 8
Izmir 7
Miami Beach 7
Washington 7
Cagliari 6
London 6
Boydton 5
Centro 5
Dallas 5
Shenzhen 5
Tbilisi 5
Tolentino 5
New York 4
Pune 4
Rome 4
Beijing 3
Freiburg im Breisgau 3
Guangzhou 3
San Diego 3
Southwark 3
Taipei 3
Adelaide 2
Amsterdam 2
Arbroath 2
Bitola 2
Brussels 2
Budapest 2
Carisio 2
Charlottesville 2
Chengdu 2
Civitanova Marche 2
Huntingdon Valley 2
Istanbul 2
Jinhua 2
Kochi 2
Porto Sant'elpidio 2
Torrent 2
Umbertide 2
Wandsworth 2
Wuhan 2
Bacolod City 1
Bologna 1
Council Bluffs 1
Falconara Marittima 1
Falls Church 1
Fuzhou 1
Helsinki 1
Islington 1
Jiaxing 1
Kazmierz 1
Kilburn 1
Kolkata 1
Lianyun 1
Magelang 1
Margate 1
Medford 1
Monsampolo del Tronto 1
Nanjing 1
New Bedfont 1
Norwalk 1
Osaka 1
Potomac 1
Prineville 1
Quanzhou 1
Rahway 1
Redwood City 1
Resana 1
Richland 1
Santa Clara 1
Seoul 1
Suzhou 1
Vienna 1
Villongo 1
Visakhapatnam 1
Yiwu 1
Totale 781
Nome #
Biomedical analysis of New Psychoactive Substances (NPS) of natural origin 100
Is etizolam a safe medication? Effects on psychomotor perfomance at therapeutic dosages of a newly abused psychoactive substance 88
Profiling of in vitro metabolism of New Psychoactive Substances 88
A comprehensive HPLC–MS-MS screening method for 77 new psychoactive substances, 24 classic drugs and 18 related metabolites in blood, urine and oral fluid 84
A Review of Synthetic Cathinone-Related Fatalities From 2017 to 2020 79
Disposition of cannabidiol metabolites in serum and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis 76
Monitoring Prenatal Exposure to Buprenorphine and Methadone 72
Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids 68
Development and validation of fast UHPLC-MS/MS screening method for 87 NPS and 32 other drugs of abuse in hair and nails: application to real cases 61
In silico prediction, LC-HRMS/MS analysis, and targeted/untargeted data-mining workflow for the profiling of phenylfentanyl in vitro metabolites 45
3F-α-pyrrolydinovalerophenone (3F-α-PVP) in vitro human metabolism: Multiple in silico predictions to assist in LC-HRMS/MS analysis and targeted/untargeted data mining 42
Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances 40
Adulterants in drugs of abuse: a recent focus of a changing phenomenon 29
Commentary: Tele-COVID-19: Does it improve the provision of health services? 28
Disposition of Hexahydrocannabinol Epimers and Their Metabolites in Biological Matrices following a Single Administration of Smoked Hexahydrocannabinol: A Preliminary Study 21
β'-Phenylfentanyl Metabolism in Primary Human Hepatocyte Incubations: Identification of Potential Biomarkers of Exposure in Clinical and Forensic Toxicology 19
The first LC-MS/MS stereoselective bioanalytical methods to quantitatively detect 9R- and 9S-hexahydrocannabinols and their metabolites in human blood, oral fluid and urine 15
Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances 15
QuEChERS Extraction and Simultaneous Quantification in GC-MS/MS of Hexahydrocannabinol Epimers and Their Metabolites in Whole Blood, Urine, and Oral Fluid 11
Liquid Chromatography High-Resolution Mass Spectrometry in Forensic Toxicology: What are the Specifics of Method Development, Validation and Quality Assurance for Comprehensive Screening Approaches? 10
The new synthetic benzimidazole opioid etonitazepipne: an emerging fatal harm and a challenge for laboratory medicine 10
Sweat Testing for the Detection of Methylone after Controlled Administrations in Humans 9
Liquid chromatography in forensic toxicology 8
Editorial: Psychiatric and Pharmacotoxicological Insights on Appearance and Performance Enhancing Drugs 8
Molecular Insights of New Psychoactive Substances (NPS) 2.0 8
Analysis of perfluoroalkyl substances ({PFAS}) in conventional and unconventional matrices: Clinical outcomes 7
Synthetic Benzimidazole Opioids: The Emerging Health Challenge for European Drug Users 7
Editorial: Drug-drug interactions in pharmacology 6
“Tranq-dope”: The first fatal intoxication due to xylazine-adulterated heroin in Italy 6
Target Analysis of NPS in Oral Fluid 5
Comprehensive Monitoring of Psychoactive Substances in Psychiatric Patients Using Liquid Chromatography-High-Resolution Mass Spectrometry: A Key Tool for Treatment Planning and Understanding Consumption Patterns in Rome, Italy. 5
null 5
Hexahydrocannabinol Pharmacology, Toxicology, and Analysis: The First Evidence for a Recent New Psychoactive Substance 4
The importance of updatable analytical screening methods for new psychoactive substances in clinical and forensic toxicology 3
The targeted analysis of New Psychoactive Substances in oral fluid through chromatographic-spectrometric methods: review of recent findings 2
Totale 1.084
Categoria #
all - tutte 7.518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.518


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0 0 0 0 0 2 2 0 2 0 4 4
2020/2021155 5 2 6 1 2 18 32 1 25 16 24 23
2021/2022100 2 11 4 0 0 7 4 6 10 12 16 28
2022/2023378 29 40 21 20 19 113 1 24 71 0 31 9
2023/2024242 34 4 27 23 33 26 7 17 4 10 17 40
2024/2025195 101 60 28 6 0 0 0 0 0 0 0 0
Totale 1.084